EU Pharma Reform: Exclusivity Vouchers Alone Are Insufficient Incentive For Antimicrobials, Industry Says

 
• By Eliza Slawther
  
Transferable exclusivity vouchers could help tackle antimicrobial resistance (Shutterstock)

More from EU Pharma Legislation Reform

More from Market Access